Atorvastatin in Management of Newly Diagnosed ITP

This single centre prospective study conducted through Qilu Hospital in affiliation with Shandong University focuses on assessing the efficacy and safety of atorvastatin (also known as Lipitor) in the treatment of adults with ITP between the ages of 18-80 years, who do not have bleeding associated with a low platelet count under 30K microliters. Participants can expect to receive atorvastatin for one year if assigned to the experimental group.


Status: On-hold

back to top

Charity NavigatorGuideStar Seal NORD Member BadgeTHSNA logo